New eye scanner could spot hidden signs of blindness
NCT ID NCT07298174
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new, non-invasive eye scanner called wide field OCTA in 200 people with various eye diseases, including age-related macular degeneration, diabetic retinopathy, and dry eye. The goal is to see if this device can provide better images of blood vessels in the back and front of the eye than current standard tools. Researchers hope it will help doctors diagnose and track eye diseases more accurately.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Wide field OCTA imaging device
- What this could lead to
- If successful, this could lead to better, non-invasive diagnosis and monitoring of eye diseases like macular degeneration and diabetic retinopathy.
- What could go wrong
- This is an early observational study, not a treatment trial. The device may not prove more useful than existing methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (AMD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Smart glasses aim to stop nearsightedness before it starts
- Can a pair of glasses slash motorcycle crashes?
- Virtual streets could shape Kids' vision and feelings
- AI eye doctor: could software catch diabetic blindness sooner?
- Can a new eye injection preserve vision in south asians with diabetes?